SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-000322
Filing Date
2019-03-14
Accepted
2019-03-14 17:22:11
Documents
1
Period of Report
2019-03-13

Document Format Files

Seq Description Document Type Size
1 form4-03142019_020358.html 4  
1 form4-03142019_020358.xml 4 5365
  Complete submission text file 0001415889-19-000322.txt   6827
Mailing Address FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076
Business Address
SAXE JON S (Reporting) CIK: 0001114914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 19681970

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations